BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20130310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20131103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20140309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20141102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20150308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20151101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20140811
DTEND;VALUE=DATE:20140815
DTSTAMP:20140607T205601Z
CREATED:20140607T205601Z
LAST-MODIFIED:20140607T205601Z
UID:8121-1407715200-1408060799@globalbiodefense.com
SUMMARY:ImVacS 2014
DESCRIPTION:The 9th Annual ImVacS 2014 Immunotherapies and Vaccine Summit will be held August 11-14\, 2014 in Boston\, Massachusetts. \nImVacS 2014 brings together a global audience of vaccine researchers and developers of cancer immunotherapies for five focused meetings that explore the frontiers of immunology as the basis for patient treatment. 250+ researchers from around the world gather to discuss new data\, new approaches and novel science from industry\, academia\, regulatory\, and research institutes in a collegial atmosphere that encourages interaction and information sharing. \nHighlighted presentations include: \n\nThe Regulatory Outlook for Future Vaccine Adjuvants\nNovel Use of an NIR Laser to Adjuvant Vaccines\nDevelopment of an Adjuvanted Recombinant Subunit Vaccine against Dengue\nSynthetic Genomics to Address Emerging Threats and Global Supply Challenges\nPutting Cancer in Check with Novel Immunomodulatory Strategies\nCAR T Cells from the Mouse Cage to the Patients’ Health\nVaccine Adjuvants: Where We Are Today and What Is Needed for the Future\nAntiviral and Adjuvant Activities of RIG-I Agonists\nThe New Revolution in Nucleic Acid Vaccines\nMonitoring B Cell Development and Ig Gene Usage for Vaccine Development\nSynthetic DNA Vaccines for Difficult Targets\nSynthetic Influenza Vaccine Viruses\nDevelopment of an Inactivated Nasal Influenza Vaccine\nDevelopment of a Second Generation Thermostable Recombinant Influenza Vaccine\nHost Response to Pertussis Infection and Vaccination in the Baboon\nDatabases and in silico Tools for Vaccine Design\nDeep Profiling of HIV-Specific T Cell Responses by Mass Cytometry\nGenomic Analysis of Vaccine Response in Humans\nNovel Vaccine Candidates Using a Robust Immunogen Optimization\nInnovative Preclinical Models for Developing Staphylococcus aureus Vaccines\nNanosponge Toxoid for Safe and Effective Vaccination\n\nAbstracts for ImVacS 2014 must be submitted and approved by July 18\, 2014. \nPlease visit Cambridge Healthtech Institute’s ImVacS 2014 Immunotherapies and Vaccine website for more information and to register to attend.
URL:https://globalbiodefense.com/event/imvacs-2014/
LOCATION:Marriott Long Wharf Hotel\, 296 State St\, Boston\, MA\, 02109\, United States
END:VEVENT
END:VCALENDAR